Metal complexes

Abstract

The invention relates to the field of electronic devices, in particular to the field of organic electroluminescent devices. The invention discloses a metal complex, a method for preparing the metal complex and an organic electroluminescent device comprising the metal complex. The metal complex is a compound of formula (1), M (L) n (L ') m formula (1), which contains a substructure of formula (2) M (L) n: # imgabs0 #. The metal complex can be used as an active component in an electronic device. The invention also provides the use of the metal complexes in electronic devices.

Description

[0001] This application is a divisional application of Chinese invention patent application No. 202080026042.6 (the corresponding international patent application number is PCT / EP2020 / 060368), with a priority date of April 15, 2019 and an invention name of “Metal Complex”. Technical Field

[0002] The present invention relates to a metal complex which is suitable for use as a light emitter in an organic electroluminescent device. Background Art

[0003] In organic electroluminescent devices (OLEDs) using organic semiconductors as functional materials, the luminescent materials used are generally organometallic complexes that display phosphorescence rather than fluorescence. In general, there is still a need to improve OLEDs that display triplet luminescence, especially in terms of efficiency, operating voltage and lifespan. The triplet luminophores used are particularly iridium complexes and platinum complexes. The iridium complexes used are particularly di-ortho-metallized and tri-ortho-metallized complexes with aromatic ligands, wherein the ligands are bound to the metal via negatively charged carbon atoms and uncharged nitrogen atoms. Examples of such complexes are imidazoisoquinoline complexes, for example according to WO 2010 / 086089 or WO 2011 / 157339, or imidazophenanthridine complexes, for example according to US2012 / 0153816 or US2015 / 0295189, wherein the ligands are coordinated to iridium via a six-membered ring and a five-membered ring in each case. Summary of the invention

[0004] It was an object of the present invention to provide novel metal complexes which are suitable as emitters for use in OLEDs, in particular for emission colors in the range from green to red, and which lead to good efficiencies and long lifetimes.

[0005] It has surprisingly been found that specific metal chelate complexes described in detail below are very suitable for use in organic electroluminescent devices. The present invention therefore provides these metal complexes and organic electroluminescent devices comprising these complexes.

[0006] The present invention provides a compound of formula (1),

[0007] M(L) n (L') m Formula (1)

[0008] It contains the substructure M(L) of formula (2) n :

[0009]

[0010] The symbols and notations used are as follows:

[0011] M is iridium or platinum;

[0012] D is C or N, one of D is C and the other D is N;

[0013] X is the same or different in each instance and is CR or N;

[0014] R is identical or different in each case and is H, D, F, Cl, Br, I, N (R 1 )2,CN,NO2,OR 1 , SR 1 ,COOR 1 ,C(=O)N(R 1 )2,Si(R 1 )3,B(OR 1 )2,C(=O)R 1 , P(=O)(R 1 )2,S(=O)R 1 , S(=O)2R 1 ,OSO2R 1 , a straight-chain alkyl group having 1 to 20 carbon atoms, or an alkenyl or alkynyl group having 2 to 20 carbon atoms, or a branched or cyclic alkyl group having 3 to 20 carbon atoms, wherein the alkyl, alkenyl or alkynyl group may in each case be replaced by one or more R 1 group, wherein one or more non-adjacent CH2 groups may be replaced by Si(R 1 )2. C=O、NR 1 , O, S or CONR 1 or having 5 to 60 aromatic ring atoms, preferably 5 to 40 aromatic ring atoms and in each case may be replaced by one or more R 1 Aromatic or heteroaromatic ring systems substituted with R groups; at the same time, the two R groups together can also form an aliphatic, heteroaliphatic, aromatic or heteroaromatic ring system;

[0015] R 1 are the same or different in each case and are H, D, F, Cl, Br, I, N (R 2 )2,CN,NO2,OR 2 , SR 2 ,Si(R 2 )3,B(OR 2 )2,C(=O)R 2 , P(=O)(R 2 )2,S(=O)R 2 , S(=O)2R 2 ,OSO2R 2, a linear alkyl group having 1 to 20 carbon atoms, or an alkenyl or alkynyl group having 2 to 20 carbon atoms, or a branched or cyclic alkyl group having 3 to 20 carbon atoms, wherein the alkyl, alkenyl or alkynyl group may be each replaced by one or more R 2 group, wherein one or more non-adjacent CH2 groups may be replaced by Si(R 2 )2. C=O、NR 2 , O, S or CONR 2 wherein one or more hydrogen atoms in the alkyl, alkenyl or alkynyl group may be replaced by D, F, Cl, Br, I or CN, or have 5 to 40 aromatic ring atoms and in each case may be replaced by one or more R 2 Aromatic or heteroaromatic ring system substituted with a group; at the same time, two or more R 1 The groups together may form an aliphatic, heteroaliphatic, aromatic or heteroaromatic ring system;

[0016] R 2 are in each case identical or different and are H, D, F, CN, or an aliphatic, aromatic or heteroaromatic organic radical having 1 to 20 carbon atoms, in particular a hydrocarbon radical, in which one or more hydrogen atoms may also be replaced by F;

[0017] L' is in each case identical or different and is a ligand;

[0018] n is 1, 2, or 3;

[0019] m is 0, 1, 2, 3, or 4;

[0020] At the same time, two or more ligands L may be linked together or L may be linked to L' via a single bond or a divalent or trivalent bridging group to form a tridentate, tetradentate, pentadentate or hexadentate ligand system. DETAILED DESCRIPTION

[0021] Aryl groups in the context of the present invention contain 6 to 40 carbon atoms; heteroaryl groups in the context of the present invention contain 2 to 40 carbon atoms and at least one heteroatom, with the proviso that the sum of carbon atoms and heteroatoms is at least 5. The heteroatoms are preferably selected from N, O and / or S. Preferably, the heteroaryl groups contain 1, 2 or 3 heteroatoms, not more than one of which is selected from O and S. An aryl group or a heteroaryl group is understood here to mean a simple aromatic ring, i.e. benzene, or a simple heteroaromatic ring, such as pyridine, pyrimidine, thiophene, etc., or a fused aryl or heteroaryl group, such as naphthalene, anthracene, phenanthrene, quinoline, isoquinoline, etc.

[0022] Aromatic ring systems in the context of the present invention contain 6 to 60 carbon atoms in the ring system. Heteroaromatic ring systems in the context of the present invention contain 1 to 60 carbon atoms and at least one heteroatom in the ring system, provided that the sum of carbon atoms and heteroatoms is at least 5. The heteroatoms are preferably selected from N, O and / or S. An aromatic or heteroaromatic ring system in the context of the present invention is to be understood as meaning a system which does not necessarily contain only aryl or heteroaryl groups, but rather in which a plurality of aryl or heteroaryl groups can also be interrupted by non-aromatic units (preferably less than 10% of non-H atoms), such as carbon, nitrogen or oxygen atoms or carbonyl groups. For example, systems such as 9,9'-spirobifluorene, 9,9-diarylfluorene, triarylamines, diaryl ethers, stilbenes, etc. are therefore also to be regarded as aromatic ring systems in the context of the present invention, as well as systems in which two or more aryl groups are interrupted, for example, by linear or cyclic alkyl groups or by silyl groups. Furthermore, systems in which two or more aryl or heteroaryl groups are bonded directly to one another, such as biphenyl or terphenyl, are likewise regarded as aromatic or heteroaromatic ring systems.

[0023] Cyclic alkyl, alkoxy or thioalkoxy groups in the context of the present invention are understood to mean monocyclic, bicyclic or polycyclic groups. The term "aliphatic ring system" in the context of the present invention also includes heteroaliphatic ring systems when two or more substituents together form an aliphatic ring system.

[0024] In the context of the present invention, C1 to C2 groups in which individual hydrogen atoms or CH2 groups may also be substituted by the abovementioned radicals are 40Alkyl groups are understood to mean, for example, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, cyclobutyl, 2-methylbutyl, n-pentyl, sec-pentyl, tert-pentyl, 2-pentyl, neopentyl, cyclopentyl, n-hexyl, sec-hexyl, tert-hexyl, 2-hexyl, 3-hexyl, neohexyl, cyclohexyl, 1-methylcyclopentyl, 2-methylpentyl, n-heptyl, 2-heptyl, 3-heptyl, 4-heptyl , cycloheptyl, 1-methylcyclohexyl, n-octyl, 2-ethylhexyl, cyclooctyl, 1-bicyclo[2.2.2]octyl, 2-bicyclo[2.2.2]octyl, 2-(2,6-dimethyl)octyl, 3-(3,7-dimethyl)octyl, adamantyl, trifluoromethyl, pentafluoroethyl, 2,2,2-trifluoroethyl, 1,1-dimethyl-n-hexan-1-yl, 1,1-dimethyl-n-heptan-1-yl, 1,1-dimethyl 1,1-dimethyl-n-octane-1-yl, 1,1-dimethyl-n-decane-1-yl, 1,1-dimethyl-n-dodecane-1-yl, 1,1-dimethyl-n-tetradecane-1-yl, 1,1-dimethyl-n-hexadecane-1-yl, 1,1-dimethyl-n-octadecane-1-yl, 1,1-diethyl-n-hexane-1-yl, 1,1-diethyl-n-heptane-1-yl, 1,1-diethyl-n-octane-1-yl, 1,1-diethyl-n-hexane-1-yl, Alkenyl groups are understood to mean, for example, ethynyl, propynyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptyl, cycloheptenyl, octenyl, cyclooctenyl or cyclooctadienyl. Alkynyl groups are understood to mean, for example, ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl or octynyl. C1 to C 40 An alkoxy group is understood to mean, for example, methoxy, trifluoromethoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy or 2-methylbutoxy.

[0025] An aromatic or heteroaromatic ring system having 5 to 60 aromatic ring atoms which may in each case also be substituted by the abovementioned radicals and which may be attached to the aromatic or heteroaromatic system via any desired position is understood as meaning, for example, a radical which is derived from benzene, naphthalene, anthracene, benzanthracene, phenanthrene, triphenylene, pyrene, lettuce, perylene, fluoranthene, benzofluoranthene, tetracene, pentacene, benzopyrene, biphenyl, biphenylylidene, terphenyl, biphenylylidene, fluorene, spirobifluorene, dihydrophenanthrene, dihydropyrene, tetrahydropyrene, cis- or trans-indenofluorene, cis- or trans-monobenzoindenofluorene, cis- or trans-dibenzoindenofluorene, trimerized indene, isotrimerized indene, spirotrimerized indene, spiroisotrimerized indene, furan, benzofuran, isobenzofuran, dibenzofuran, thiophene, benzothiophene, isobenzothiophene, dibenzothiophene, pyrrole, indole, isoindole, carbazole, indolocarbazole, indenocarbazole, pyridine, quinoline, isoquinoline, acridine, phenanthridine, benzo-5,6-quinoline, benzo-6,7-quinoline, benzo-7,8-quinoline, phenothiazine, phenanthroline, azine, pyrazole, indazole, imidazole, benzimidazole, naphthimidazole, phenanthimidazole, pyridimidazole, pyrazimidazole, quinoxalineimidazole, Azoles, benzo Azoles, naphtho Azoles, anthracenes Azoles, phenanthracenes Azoles, Isopropylamine azole, 1,2-thiazole, 1,3-thiazole, benzothiazole, pyridazine, benzopyridazine, pyrimidine, benzopyrimidine, quinoxaline, 1,5-diazaanthracene, 2,7-diazapyrene, 2,3-diazapyrene, 1,6-diazapyrene, 1,8-diazapyrene, 4,5-diazapyrene, 4,5,9,10-tetraazaperylene, pyrazine, phenazine, phen Oxazine, phenothiazine, fluorescent red ring, naphthyridine, azacarbazole, benzocarboline, phenanthroline, 1,2,3-triazole, 1,2,4-triazole, benzotriazole, 1,2,3- Oxadiazole, 1,2,4- Oxadiazole, 1,2,5- Oxadiazole, 1,3,4- oxadiazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole, 1,3,5-triazine, 1,2,4-triazine, 1,2,3-triazine, tetrazole, 1,2,4,5-tetrazine, 1,2,3,4-tetrazine, 1,2,3,5-tetrazine, purine, pteridine, indolizine and benzothiadiazole.

[0026] In the context of the present specification, the expression that two or more radicals together can form an aliphatic ring is understood to mean, in particular, that the two radicals are linked to one another via a chemical bond and formally eliminate two hydrogen atoms. This is illustrated by the following scheme:

[0027]

[0028] The formation of fused aromatic or heteroaromatic groups is also possible, as illustrated by the following scheme:

[0029]

[0030] However, in addition, the above wording should also be understood to mean that if one of the two groups is hydrogen, the second group is bonded to the position where the hydrogen atom is bonded, thereby forming a ring. This will be illustrated by the following scheme:

[0031]

[0032] Preference is given to compounds of the formula (1), characterised in that they are uncharged, ie electrically neutral. This is achieved in a simple manner by selecting the charge of the ligands L and L′ such that they compensate for the charge of the complexing metal atom M.

[0033] In the complex of formula (1), the indices n and m are chosen such that the total coordination number of the metal M corresponds to the customary coordination number of the metal, depending on the metal. Iridium(III) has a coordination number of 6 and platinum(II) has a coordination number of 4.

[0034] In one embodiment of the invention, M = iridium (III), and the marker n is 1, 2 or 3, preferably 2 or 3. When the marker n = 1, four additional monodentate ligands L' or two bidentate ligands L' or one bidentate ligand L' and two monodentate ligands L' or one tridentate ligand L' and one monodentate ligand L' or one tetradentate ligand L', preferably two bidentate ligands L', coordinate with the iridium. When the marker n = 2, one bidentate ligand L' or two monodentate ligands L', preferably one bidentate ligand L', also coordinate with the iridium. When the marker n = 3, the marker m = 0.

[0035] In another embodiment of the invention, M=platinum(II) and the index n is 1 or 2. When the index n=1, one bidentate ligand L' or two monodentate ligands L', preferably one bidentate ligand L', also coordinates to the platinum M. When the index n=2, the index m=0.

[0036] Formula (2) yields two structures depending on which D group is C and which is N. These are represented by the following formulas (3) and (4):

[0037]

[0038] The symbols and signs used therein have the same definitions as above.

[0039] In a preferred embodiment of the present invention, if X is present, no more than one X is N and the other X groups are CR. More preferably, the symbol X in the two six-membered rings is CR, or one symbol X in the six-membered ring coordinated via a carbon atom is N and the other symbol X in the two six-membered rings is CR, and exactly one symbol X in the five-membered ring is N. Preferred embodiments of formula (3) are the structures of formulas (3a) to (3f) below, and preferred embodiments of formula (4) are the structures of formulas (4a) to (4f) below:

[0040]

[0041]

[0042] The symbols and notations used therein have the definitions given above.

[0043] Preferably, the structure of formula (2) is the structure of the following formulas (3a-1) to (4f-1):

[0044]

[0045]

[0046] The symbols and indices used therein have the meanings given above, and R' has the same meaning as R, wherein at least one substituent R' is not H or D.

[0047] The structures of formula (3) or (3a) to (3c) are preferred. The structure of formula (3a) is particularly preferred.

[0048] Depending on the substituents and the ring formed by the substituents, the triplet energy of the unit of formula (2) and thus the emission color can be influenced. For example, if two substituents R in the five-membered ring of formulae (3a), (3c), (3d), (4a), (4c) and (4d) together form a fused benzene ring, this reduces IrL n The triplet energy of the unit, thus leading to IrL n Redshift of the unit's luminescence.

[0049] As mentioned above, adjacent R groups together can form an aliphatic, aromatic or heteroaromatic ring system. In one embodiment of the present invention, two adjacent R groups on the five-membered ring together form a fused benzo group, which can be fused by one or more R 1 A preferred embodiment is the structure of formula (3a-2) to (4a-6),

[0050]

[0051]

[0052] The symbols and notations used therein have the definitions given above.

[0053] Preferred R groups are identical or different in each case and are selected from: H, D, F, Br, I, N (R 1 )2,CN,Si(R 1 )3,B(OR 1 )2, a linear alkyl group having 1 to 10 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms, or a branched or cyclic alkyl group having 3 to 10 carbon atoms, each of which may be replaced by one or more R 1 a substituted radical in which one or more hydrogen atoms may be replaced by D or F, or having 5 to 24 aromatic ring atoms and in each case by one or more R 1 At the same time, two preferably adjacent R groups together can also form an aliphatic, heteroaliphatic, aromatic or heteroaromatic ring system. More preferably, these R groups are in each case identical or different and are selected from: H, D, F, N (R 1 )2, CN, a straight-chain alkyl radical having 1 to 6 carbon atoms, or an alkenyl radical having 2 to 6 carbon atoms, or a branched or cyclic alkyl radical having 3 to 10 carbon atoms, in which one or more hydrogen atoms may be replaced by D or F, or having 6 to 13 aromatic ring atoms and in each case may be replaced by one or more R 1 At the same time, two adjacent R groups together can also form an aliphatic or aromatic ring system.

[0054] Preferred R 1 The radicals are identical or different in each case and are H, D, F, CN, a straight-chain alkyl radical having 1 to 10 carbon atoms, or an alkenyl radical having 2 to 20 carbon atoms, or a branched or cyclic alkyl radical having 3 to 10 carbon atoms, each of which may be replaced by one or more R 2 a radical in which one or more hydrogen atoms may be replaced by F, or having 5 to 24 aromatic ring atoms and in each case by one or more R 2 Aromatic or heteroaromatic ring system substituted with a radical; at the same time, two or more adjacent R 1 The radicals together can form an aliphatic, aromatic or heteroaromatic ring system. Particularly preferred R 1 The radicals are identical or different in each case and are H, D, F, a straight-chain alkyl radical having 1 to 4 carbon atoms, or a branched or cyclic alkyl radical having 3 to 6 carbon atoms, or an aromatic or heteroaromatic ring system having 6 to 13 aromatic ring atoms, each of which may be replaced by one or more R 2Groups are substituted, but preferably are unsubstituted; at the same time, two or more adjacent R 1 The groups together can form an aliphatic or aromatic ring system.

[0055] Preferred R 2 The radical is selected from H, D, F, CN, an alkyl radical having 1 to 6 carbon atoms or an aromatic ring system having 6 to 12 carbon atoms.

[0056] In another embodiment of the present invention, two adjacent R groups together form an aliphatic ring system. The adjacent groups may be on one or both of the six-membered ring and / or the five-membered ring. Preferred aliphatic ring systems are selected from the structures of the following formulae (5) to (11):

[0057]

[0058] Where R 1 and R 2 Having the definitions given above, a dashed bond represents the connection of two carbon atoms in a ligand, and in addition:

[0059] G is a carbon atom having 1, 2 or 3 carbon atoms and may be replaced by one or more R 2 Alkylene group substituted with a radical, -CR 2 =CR 2 - or having 5 or 6 aromatic ring atoms and may be replaced by one or more R 2 a radical-substituted ortho-bonded arylene or heteroarylene group;

[0060] R 3 In each case the same or different and is F, OR 2 , a straight-chain alkyl radical having 1 to 10 carbon atoms, a branched or cyclic alkyl radical having 3 to 10 carbon atoms, wherein the alkyl radical may be replaced by one or more R 2 group, wherein one or more non-adjacent CH2 groups may be replaced by R 2 C=CR 2 、C≡C、Si(R 2 )2. C=O、NR 2 , O, S or CONR 2 or have 5 or 6 aromatic ring atoms and in each case may be replaced by one or more R 2 substituted aryl or heteroaryl groups; at the same time, the two R 3 The groups may together form an aliphatic ring system and thus a spiro ring system; in addition, R 3 With adjacent R or R 1 The groups may form an aliphatic ring system.

[0061] In the structures of formulae (5) to (11) depicted above and other embodiments in which these structures are designated as preferred, a double bond is depicted between two carbon atoms in a formal sense. This is a simplification of the chemical structure in which the two carbon atoms are incorporated into an aromatic or heteroaromatic system and thus the bond between the two carbon atoms is formally intermediate between a single bond and a double bond.

[0062] Preferred embodiments of the groups of formulae (5) to (11) can be found in patent applications WO 2014 / 023377, WO 2015 / 104045 and WO 2015 / 117718.

[0063] As mentioned above, in the compounds of the invention, there may also be a bridging unit that connects the ligand L to one or more additional ligands L or L' instead of one R group. In a preferred embodiment of the invention, there is a bridging unit that replaces one of the R groups located in the ortho or meta position of the coordinating atom on one of the coordinating six-membered rings, especially in the meta position of the coordinating atom, so that the ligand has a tridentate or multidentate or multipodal character. There may also be two such bridging units. This leads to the formation of macrocyclic ligands or the formation of cryptates.

[0064] Preferred structures having multidentate ligands are metal complexes of the following formulae (12) to (15):

[0065]

[0066] The symbols and indices used therein have the definitions given above. L' is preferably a bidentate ligand, in particular a monoanionic bidentate ligand coordinated via a carbon atom and a nitrogen atom.

[0067] V in the structures of the formulae (14) and (15) is preferably selected from BR 1 , B(R 1 )2 – , C(R 1 )2、C(=O)、Si(R 1 )2. NR 1 , PR 1 , P(R 1 )2 + ,P(=O)(R 1 )、P(=S)(R 1 ), O, S, Se, or a unit of one of formulas (16) to (25),

[0068]

[0069] wherein the dashed bonds each represent a bond to the subligand L or L', Q is in each case identical or different and is C(R 1 )2、N(R 1), O or S, Z is in each case the same or different and is selected from a single bond, O, S, S(=O), S(=O)2, NR 1 , PR 1 、P(=O)R 1 , C(R 1 )2、C(=O)、C(=NR 1 )、C(=C(R 1 )2)、Si(R 1 )2 and BR 1 , and other symbols used each have the definitions detailed above.

[0070] In addition, V in the structures of formula (12) and (13) is preferably a group of the following formula (26), wherein the dotted bond indicates the connection position of the sub-ligands L and L':

[0071]

[0072] in:

[0073] X 1 are the same or different and are CR or N in each case;

[0074] A is identical or different in each case and is CR2-CR2, CR2-O, CR2-NR, C(=O)-O, C(=O)-NR or a radical of the following formula (27):

[0075]

[0076] wherein the dashed bonds in each case indicate the bonding position of the bidentate ligands L and L′ to the structure, * indicates the attachment position of the unit of formula (27) to the central trivalent aryl or heteroaryl group, and X 2 are identical or different and are CR or N in each case.

[0077] When X 2 =CR, the preferred substituents in the group of formula (27) are selected from the substituents R mentioned above.

[0078] In a preferred embodiment of the invention, A is identical or different in each case and is CR2-CR2 or a group of formula (27). The following embodiments are preferred:

[0079] - all three A groups are identical groups of formula (27);

[0080] - two A groups are identical groups of formula (27) and the third A group is CR2-CR2;

[0081] - one A group is a group of formula (27) and the other two A groups are identical CR2-CR2 groups; or

[0082] - All three A groups are identical CR2-CR2 groups.

[0083] Here, "the same group of formula (27)" means that these groups all have the same basic skeleton and the same substitution. In addition, "the same CR2-CR2 group" means that these groups all have the same substitution.

[0084] When A is CR2-CR2, R is preferably identical or different at each occurrence and is H or D, more preferably H.

[0085] The group of formula (27) is an aromatic or heteroaromatic six-membered ring. In a preferred embodiment of the present invention, the group of formula (27) contains no more than one heteroatom in the aromatic or heteroaryl group. This does not mean that any substituent bonded to the group cannot also contain a heteroatom. In addition, this definition does not mean that the ring formed by the substituent will not produce a fused aromatic or heteroaromatic structure, such as naphthalene, benzimidazole, etc. The group of formula (27) is preferably selected from benzene, pyridine, pyrimidine, pyrazine and pyridazine.

[0086] Preferred embodiments of the group of formula (27) are the structures of the following formulae (28) to (35):

[0087]

[0088] The symbols used therein have the definitions given above.

[0089] Particular preference is given to optionally substituted radicals of the formulae (28) to (32). Very particular preference is given to o-phenylene, ie radicals of the formula (28).

[0090] At the same time, as also detailed above in the description of substituents, adjacent substituents may also be combined to form a ring system so that fused structures may be formed, including fused aryl and heteroaryl groups, such as naphthalene, quinoline, benzimidazole, carbazole, dibenzofuran or dibenzothiophene.

[0091] Preferred embodiments of the group of formula (26) are the structures of the following formulae (36) to (39):

[0092]

[0093] The symbols used therein have the definitions given above.

[0094] More preferably, all substituents R in the central ring of formulae (36) to (39) are H, so the structure is preferably selected from formulae (36a) to (39a),

[0095]

[0096] The symbols used therein have the definitions given above.

[0097] More preferably, the groups of formulae (36) to (39) are selected from the structures of the following formulae (36b) to (39b):

[0098]

[0099] wherein R is in each case identical or different and is H or D, preferably H. Preferred ligands L' occurring in formula (1) are described below. When the ligand L' is bonded to L via a bridging V unit, the ligand L' can also be selected accordingly.

[0100] The ligands L' are preferably uncharged monoanionic, dianionic or trianionic ligands, more preferably uncharged or monoanionic ligands, especially monoanionic ligands. They can be monodentate, bidentate, tridentate or tetradentate and are preferably bidentate, i.e. preferably have two coordination sites. As mentioned above, the ligands L' can also be bonded to L via a bridging V group. More preferably, the ligands L' are bidentate and monoanionic.

[0101] Preferred uncharged monodentate ligands L' are selected from carbon monoxide; nitrogen monoxide; alkyl cyanides, for example acetonitrile; aryl cyanides, for example benzonitrile; alkyl isocyanides, for example methyl isocyanide; aryl isocyanides, for example benzyl isocyanide; amines, for example trimethylamine, triethylamine, morpholine; phosphines, in particular halogenated phosphines, trialkylphosphines, triarylphosphines or alkylarylphosphines, for example trifluorophosphine, trimethylphosphine, tricyclohexylphosphine, tri-tert-butylphosphine, triphenylphosphine, tri(pentafluorophenyl)phosphine, dimethylphenylphosphine, methyldiphenylphosphine, bis(tert-butyl)phenylphosphine; phosphites, for example trimethyl phosphite, triethyl phosphite; arsines, for example trifluoroarsine, trimethylarsine, tricyclohexylarsine, tri-tert-butylarsine, triphenylarsine, tri(pentafluorophenyl)arsine; For example, trifluoro Trimethyl Tricyclohexyl Tri-tert-butyl Triphenyl Tris(pentafluorophenyl) Nitrogen-containing heterocycles, for example pyridine, pyridazine, pyrazine, pyrimidine, triazine; and carbene, especially Arduengo carbene.

[0102] Preferred monoanionic monodentate ligands L' are selected from hydrogen anions; deuterium anions; halide anions F - , Cl - Br - and I - ; alkyl acetylene anions, such as methyl -C≡C - tert-butyl-C≡C- ; aryl acetylene anions, such as phenyl-C≡C - ; Cyanide anion; Cyanate anion; Isocyanate anion; Thiocyanate anion; Isothiocyanate anion; Aliphatic or aromatic alcohol anion, such as methanol anion, ethanol anion, propanol anion, isopropanol anion, tert-butanol anion, phenol anion; Aliphatic or aromatic thiol anion, such as methanethiol anion, ethanethiol anion, propanethiol anion, isopropanethiol anion, tert-butanethiol anion, thiophenol anion; Ammonium anion, such as dimethylammonium anion, diethylammonium anion, diisopropylammonium anion; Morpholine anion; Carboxylic acid anion, such as acetate anion, trifluoroacetate anion, propionate anion, benzoate anion; Aryl group, such as phenyl, naphthyl; And anionic nitrogen-containing heterocyclic compounds, such as pyrrole anion, imidazolium anion, pyrazolium anion. At the same time, the alkyl group in these groups is preferably C1-C 20 Alkyl groups, more preferably C1-C 10 Alkyl groups, most preferably C1-C4 alkyl groups. Aryl groups are also understood to mean heteroaryl groups. These groups have the definitions given above.

[0103] Preferred di- or tri-anionic ligands are O 2- , S 2- , resulting in a carbanion with a coordination of the form RC≡M, and a nitrene with a coordination of the form RN=M, where R is usually a substituent, or N 3- .

[0104] Preferred uncharged or mono- or dianionic, bidentate or higher polydentate ligands L' are selected from diamines, for example ethylenediamine, N,N,N',N'-tetramethylethylenediamine, propylenediamine, N,N,N',N'-tetramethylpropylenediamine, cis- or trans-diaminocyclohexane, cis- or trans-N,N,N',N'-tetramethyldiaminocyclohexane; imines, for example 2-[1-(phenylimino)ethyl]pyridine, 2-[1-(2-methylphenylimino)ethyl]pyridine, 2-[1-(2,6-diisopropylphenylimino)ethyl]pyridine, 2-[1-(methylimino)ethyl]pyridine, 2-[1-(ethylimino)ethyl]pyridine, 2-[(1-(isopropylimino)ethyl]pyridine, 2-[1-( diimines, such as 1,2-bis(methylimino)ethane, 1,2-bis(ethylimino)ethane), 1,2-bis(isopropylimino)ethane, 1,2-bis(tert-butylimino)ethane, 2,3-bis(methylimino)butane, 2,3-bis(ethylimino)butane, 2,3-bis(isopropylimino)butane, 2,3-bis(tert-butylimino)butane, 1,2-bis(phenylimino)ethane, 1,2-bis(2-methylphenylimino)ethane, 1,2-bis(2,6-diisopropylphenylimino)ethane, 1,2-bis(2,6-di-tert-butylphenylimino)ethane, 2,3-bis(phenylimino)butane, 2,3-bis(2-methyl bis(diphenylphosphino)methane, bis(diphenylphosphino)ethane, bis(diphenylphosphino)propane, bis(diphenylphosphino)butane, bis(dimethylphosphino)methane, bis(dimethylphosphino)ethane, bis(dimethylphosphino)propane, bis(diethylphosphino)methane, bis(diethylphosphino)ethane, bis(diethylphosphino)propane, bis(di-tert-butylphosphino)methane, bis(di-tert-butylphosphino)ethane, bis(tert-butylphosphino)propane; 1,3-diketonates derived from 1,3- diketones such as acetylacetone, benzoylacetone, 1,5-diphenylacetylacetone, dibenzoylmethane, bis(1,1,1-trifluoroacetyl)methane; 3-keto anions derived from 3-keto acid esters such as ethyl acetoacetate; carboxylic acid anions derived from aminocarboxylic acids such as pyridine-2-carboxylic acid, quinoline-2-carboxylic acid, glycine, N,N-dimethylglycine, alanine, N,N-dimethylaminoalanine; salicylimide anions derived from salicylic imides such as methyl salicylic imide, ethyl salicylic imide, phenyl salicylic imide; diol anions derived from diols such as ethylene glycol, 1,3-propylene glycol; and dithiol anions derived from dithiols such as ethylene-1,2-dithiol, propylene-1,3-dithiol;Bis(pyrazolyl borate), bis(imidazolyl) borate, 3-(2-pyridyl)diazole or 3-(2-pyridyl)triazole. ;

[0105] Preferred tridentate ligands are borate esters of nitrogen-containing heterocyclic compounds, such as tetrakis(1-imidazolyl)borate and tetrakis(1-pyrazolyl)borate.

[0106] Further preference is given to bidentate monoanionic, uncharged or dianionic ligands L', in particular monoanionic ligands which, together with the metal, form a cyclometallated five-membered or six-membered ring, in particular a cyclometallated five-membered ring, with at least one metal-carbon bond. These are in particular the ligands commonly used in the field of phosphorescent metal complexes for organic electroluminescent devices, i.e. ligands of the phenylpyridine, naphthylpyridine, phenylquinoline, phenylisoquinoline type, etc., each of which may be substituted by one or more R groups. The person skilled in the art in the field of phosphorescent electroluminescent devices knows a variety of such ligands and will be able to select other ligands of this type as ligand L' for compounds of formula (1) without inventive effort. Typically, a particularly suitable combination for this purpose is a combination of two groups as shown in the following formulae (40) to (88), in which one group is preferably bound via an uncharged nitrogen atom or a carbene carbon atom, and the other group is preferably bound via a negatively charged carbon atom or a negatively charged nitrogen atom. The ligand L' can thus be formed from the groups of formulae (40) to (88) by these groups each bonding to one another at the position indicated by #. The position of the group coordinated to the metal is indicated by *. These groups can also be bonded to the ligand L via one or two bridging V units.

[0107]

[0108]

[0109]

[0110]

[0111] Here X and R have the definitions given above, and W is NR, O or S. Preferably, not more than three X symbols per group are N, more preferably not more than two X symbols per group are N, and even more preferably not more than one X symbol per group is N. Particularly preferably, all symbols X are CR.

[0112] At the same time, it is also possible to form a fused heteroaryl group from two separate aryl or heteroaryl groups by forming a ring from adjacent substituents, which coordinates to M as a bidentate ligand L'.

[0113] Other suitable co-ligands L′ are structures which are not completely heteroaromatic but have a keto group in the ligand base structure, as disclosed in WO 2011 / 044988, WO 2014 / 094962, WO 2014 / 094961 and WO 2014 / 094960.

[0114] The following table lists examples of suitable co-ligands L' in which the radicals on the individual coordinating groups form a ring system with one another, also citing the CAS number in each case:

[0115]

[0116]

[0117]

[0118] When the ligand L' consists of structures of formulae (40) to (88), when X is CR, the preferred R groups in these structures are the same as the R groups of formula (2) described in detail above.

[0119] The complexes of the invention may be in the facial or pseudo-facial form, or they may be in the meridional or pseudo-meridional form.

[0120] The above preferred embodiments can be combined with each other as needed. In a particularly preferred embodiment of the present invention, the above preferred embodiments are applicable simultaneously.

[0121] Examples of compounds of the present invention are the structures shown in the following table:

[0122]

[0123]

[0124]

[0125]

[0126]

[0127]

[0128]

[0129]

[0130]

[0131]

[0132]

[0133]

[0134]

[0135]

[0136]

[0137]

[0138]

[0139]

[0140]

[0141]

[0142]

[0143]

[0144]

[0145]

[0146]

[0147]

[0148]

[0149]

[0150]

[0151]

[0152]

[0153]

[0154]

[0155]

[0156] The present invention also provides a method for preparing a metal complex compound of formula (1), which is carried out by reacting the corresponding free ligand L and optionally L' with a metal alkoxide of formula (79), with a metal ketoketone of formula (80), with a metal halide of formula (81), with a dimeric metal complex of formula (82) or with a metal complex of formula (83),

[0157]

[0158] wherein the symbols M, m, n and R have the meanings given above, Hal═F, Cl, Br or I, L″ is an alcohol, in particular an alcohol having 1 to 4 carbon atoms, or a nitrile, in particular acetonitrile or benzonitrile, and (anion) is a non-coordinating anion, for example a trifluoromethanesulfonate anion.

[0159] It can be ensured via the temperature range of the reaction and, if necessary, the presence of blocking substituents that the ligand L is coordinated via two six-membered rings rather than via one five-membered ring and one six-membered ring. More specific details of the reaction scheme can be found in the Examples section.

[0160] It is also possible to use metal compounds, in particular iridium compounds, which carry alkoxides and / or halides and / or hydroxyl groups and carry keto-keto anionic groups. These compounds may also be charged. Corresponding iridium compounds which are particularly suitable as reactants are disclosed in WO 2004 / 085449. Particularly suitable are [IrCl2(acac)2] ─ , such as Na[IrCl2(acac)2], metal complexes with acetylacetone derivatives as ligands, such as Ir(acac)3 or tris(2,2,6,6-tetramethylheptane-3,5-dionato)iridium, and IrCl3·xH2O, where x is usually a number from 2 to 4.

[0161] Suitable platinum reactants are, for example, PtCl2, K2[PtCl4], PtCl2(DMSO)2, Pt(Me)2(DMSO)2 or PtCl2(benzonitrile)2.

[0162] The synthesis of the complex is preferably carried out as described in WO 2002 / 060910, WO 2004 / 085449 and WO 2007 / 065523. Heterolate complexes can also be synthesized, for example, according to WO 2005 / 042548. In this case, the synthesis can also be activated, for example, thermally or photochemically and / or by microwave radiation. In order to activate the reaction, Lewis acids, such as silver salts or AlCl can also be added.

[0163] The reaction can be carried out in the melt of the corresponding ligand to be ortho-metallated without adding solvents or melting aids. Optionally, solvents or melting aids can be added. Suitable solvents are protic or aprotic solvents, for example aliphatic and / or aromatic alcohols (methanol, ethanol, isopropanol, tert-butanol, etc.), oligo- and polyols (ethylene glycol, propane-1,2-diol, glycerol, etc.), alcohol ethers (ethoxyethanol, diethylene glycol, triethylene glycol, polyethylene glycol, etc.), ethers (diethylene glycol dimethyl ether and triethylene glycol dimethyl ether, diphenyl ether, etc.), aromatic, heteroaromatic and / or aliphatic hydrocarbons (toluene, xylene, mesitylene, chlorobenzene, pyridine, lutidine, quinoline, isoquinoline, tridecane, hexadecane, etc.), amides (DMF, DMAC, etc.), lactams (NMP), sulfoxides (DMSO) or sulfones (dimethyl sulfone, cyclopentane, etc.). Suitable melting aids are compounds which are solid at room temperature but melt and dissolve the reactants when the reaction mixture is heated so as to form a homogeneous melt. Particularly suitable are biphenyl, m-terphenyl, terphenylidene, 1,2-bisphenoxybenzene, 1,3-bisphenoxybenzene, 1,4-bisphenoxybenzene, triphenylphosphine oxide, 18-crown-6, phenol, 1-naphthol, hydroquinone and the like.

[0164] By these methods, if necessary followed by purification, for example recrystallization or sublimation, high purities, preferably exceeding 99% and more preferably exceeding 99.9% (by 1 H NMR and / or HPLC).

[0165] The compounds of the present invention may also be made soluble by suitable substitution, for example by being replaced by longer alkyl groups (about 4 to 20 carbon atoms), especially branched alkyl groups, or optionally substituted aryl groups, for example xylyl, mesityl or branched terphenyl or quaterphenyl groups. Thus, such compounds are soluble in standard organic solvents such as toluene or xylene at room temperature in sufficient concentrations to enable the complex to be processed from solution. These soluble compounds are particularly well suited for processing from solution, for example by printing methods.

[0166] In order to process the compounds of the invention from the liquid phase, for example by spin coating or by printing methods, preparations of the compounds of the invention are required. These preparations may be, for example, solutions, dispersions or emulsions. For this purpose, mixtures of two or more solvents may preferably be used. Suitable and preferred solvents are, for example, toluene, anisole, o-, m- or p-xylene, methyl benzoate, mesitylene, tetralin, o-dimethoxybenzene, THF, methyl-THF, THP, chlorobenzene, dimethoxybenzene, alkanes, phenoxytoluene, especially 3-phenoxytoluene, (-)-fenchone, 1,2,3,5-tetramethylbenzene, 1,2,4,5-tetramethylbenzene, 1-methylnaphthalene, 2-methylbenzothiazole, 2-phenoxyethanol, 2-pyrrolidone, 3-methylanisole, 4-methylanisole, 3,4-dimethylanisole, 3,5-dimethylanisole, acetophenone, α-terpineol, benzothiazole, butyl benzoate, isopropylbenzene, cyclohexanol, cyclohexanone, cyclohexylbenzene, decalin, dodecylbenzene, ethyl benzoate, indane, NMP, p-cymene, Phenethyl ether, 1,4-diisopropylbenzene, dibenzyl ether, diethylene glycol butyl methyl ether, triethylene glycol butyl methyl ether, diethylene glycol dibutyl ether, triethylene glycol dimethyl ether, diethylene glycol monobutyl ether, tripropylene glycol dimethyl ether, tetraethylene glycol dimethyl ether, 2-isopropylnaphthalene, pentylbenzene, hexylbenzene, heptylbenzene, octylbenzene, 1,1-bis(3,4-dimethylphenyl)ethane, 2-methylbiphenyl, 3-methylbiphenyl, 1-methylnaphthalene, 1-ethylnaphthalene, ethyl octanoate, diethyl sebacate, octyl octanoate, heptylbenzene, menthyl isovalerate, cyclohexyl hexanoate, or a mixture of these solvents.

[0167] Therefore, the present invention also provides a preparation comprising the compounds of the present invention and at least one other compound. The other compound may be, for example, a solvent. Alternatively, the other compound may be another organic or inorganic compound, such as a matrix material, which is also used in electronic devices.

[0168] The compounds of formula (1) and the preferred embodiments described above can be used as active components in electronic devices. Therefore, the present invention also provides the use of the compounds of formula (1) or the compounds according to the preferred embodiments in electronic devices.

[0169] An electronic device is understood to mean any device comprising an anode, a cathode and at least one layer, the layer comprising at least one organic or organometallic compound. Thus, the electronic device of the present invention comprises an anode, a cathode and at least one layer, the layer comprising at least one compound of formula (1) as described in detail above. Preferred electronic devices are selected from the following: organic electroluminescent devices (OLED, PLED), organic integrated circuits (O-IC), organic field effect transistors (O-FET), organic thin film transistors (O-TFT), organic light emitting transistors (O-LET), organic solar cells (O-SC), organic optical detectors, organic photoreceptors, organic field quenching devices (O-FQD), light emitting electrochemical cells (LEC) and organic laser diodes (O-lasers), which contain at least one compound of formula (1) as described in detail above in at least one layer. Organic electroluminescent devices are particularly preferred. The active component is generally an organic or inorganic material introduced between the anode and the cathode, such as a charge injection, charge transport or charge blocking material, but especially a luminescent material and a matrix material. The compounds of the present invention exhibit particularly good properties as luminescent materials in organic electroluminescent devices. Therefore, organic electroluminescent devices are a preferred embodiment of the present invention. Furthermore, the compounds according to the invention can be used to generate singlet oxygen for photocatalysis or photoconversion, for example for pixel color converters (PCCs).

[0170] The organic electroluminescent device includes a cathode, an anode and at least one light-emitting layer. In addition to these layers, it may also include another layer, for example, in each case, including one or more hole injection layers, hole transport layers, hole blocking layers, electron transport layers, electron injection layers, exciton blocking layers, electron blocking layers, charge generation layers and / or organic or inorganic p / n junctions. At the same time, one or more hole transport layers may be, for example, p-doped with metal oxides such as MoO3 or WO3 or with (per) fluorinated electron-deficient aromatic systems, and / or one or more electron transport layers may be n-doped. Intermediate layers may be introduced between two light-emitting layers, and these intermediate layers may have, for example, exciton blocking functions and / or control the charge balance in the electroluminescent device. However, it should be noted that each of these layers need not necessarily be present.

[0171] In this case, the organic electroluminescent device may comprise one luminescent layer or may comprise a plurality of luminescent layers. If a plurality of luminescent layers are present, these layers preferably have a plurality of luminescent peaks between 380 nm and 750 nm in total, so that the overall result is white luminescence; in other words, a plurality of luminescent compounds that can fluoresce or phosphoresce are used in the luminescent layer. Particularly preferred are three-layer systems, in which the three layers exhibit blue, green and orange or red luminescence (for the basic structure, see, for example, WO 2005 / 011013), or systems with more than three luminescent layers. The system may also be a mixed system in which one or more layers fluoresce and one or more other layers phosphoresce.

[0172] In a preferred embodiment of the invention, the organic electroluminescent device comprises the compound of the formula (1) or the preferred embodiments described in detail above as emitting compound in one or more emitting layers.

[0173] When the compound of formula (1) is used as a luminescent compound in a light-emitting layer, it is preferably used in combination with one or more host materials. Based on the total mixture of luminophore and host material, the mixture of the compound of formula (1) and the host material contains 0.1% to 99% by volume, preferably 1% to 90% by volume, more preferably 3% to 40% by volume and especially 5% to 15% by volume of the compound of formula (1). Accordingly, based on the total mixture of luminophore and host material, the mixture contains 99.9% to 1% by volume, preferably 99% to 10% by volume, more preferably 97% to 60% by volume and especially 95% to 85% by volume of host material.

[0174] The matrix material used may generally be any material known for this purpose according to the prior art. The triplet level of the matrix material is preferably higher than the triplet level of the emitter.

[0175] Suitable matrix materials for the compounds according to the invention are ketones, phosphine oxides, sulfoxides and sulfones, for example according to WO 2004 / 013080, WO 2004 / 093207, WO 2006 / 005627 or WO 2010 / 006680, triarylamines, carbazole derivatives, for example CBP (N,N-biscarbazolylbiphenyl), m-CBP or the carbazole derivatives disclosed in WO 2005 / 039246, US 2005 / 0069729, JP 2004 / 288381, EP 1205527, WO 2008 / 086851 or US 2009 / 0134784, for example according to WO 2007 / 063754 or WO 2008 / 056746, for example according to WO 2010 / 136109 or WO 2011 / 000455, for example according to EP 1617710, EP 1617711, EP1731584, JP 2005 / 347160, for example according to the dipole matrix materials disclosed in WO 2007 / 137725, for example according to the silanes disclosed in WO 2005 / 111172, for example according to the borazolidines or boric acid esters disclosed in WO 2006 / 117052, for example according to the siladiazolidine derivatives disclosed in WO 2010 / 054729, for example according to the phosphodiazolidine derivatives disclosed in WO 2010 / 054730, for example according to WO 2010 / 015306, WO Triazine derivatives as disclosed in WO 2007 / 063754 or WO 2008 / 056746, zinc complexes as disclosed in EP 652273 or WO 2009 / 062578, dibenzofuran derivatives as disclosed in WO 2009 / 148015, or bridged carbazole derivatives as disclosed in US 2009 / 0136779, WO 2010 / 050778, WO 2011 / 042107 or WO 2011 / 088877.

[0176] It is also possible to use a plurality of different matrix materials, in particular at least one electron-conducting matrix material and at least one hole-conducting matrix material, preferably as a mixture. Preferred combinations are, for example, the use of aromatic ketones, triazine derivatives or phosphine oxide derivatives with triarylamine derivatives or carbazole derivatives as mixed matrices for the metal complexes according to the invention. It is also preferred to use mixtures of charge-transporting matrix materials with electrically inert matrix materials which do not significantly participate, if at all, in charge transport, as described, for example, in WO 2010 / 108579.

[0177] Preferred bicarbazoles that can be used as host materials for the compounds of the present invention are the following structures (84) and (85):

[0178]

[0179] Among them, Ar 1 are identical or different and are aromatic or heteroaromatic ring systems having 5 to 40 aromatic ring atoms, preferably 6 to 30 aromatic ring atoms and which may in each case be substituted by one or more R groups, A 1 is NR, CR2, O or S, and R has the meaning given above. In a preferred embodiment of the present invention, A 1 It's CR2.

[0180] Preferred embodiments of the compounds of formula (84) and (85) are the following compounds of formula (84a) and (85a):

[0181]

[0182] The symbols used therein have the definitions given above.

[0183] Examples of suitable compounds of formula (84) and (85) are the compounds depicted below:

[0184]

[0185]

[0186]

[0187] Preferred dibenzofuran derivatives are compounds of the following formula (86):

[0188]

[0189] wherein oxygen may also be replaced by sulfur to form dibenzothiophene, L is a single bond or an aromatic or heteroaromatic ring system having 5 to 30 aromatic ring atoms and which may also be substituted by one or more R groups, and R and Ar 1 has the meaning given above. Here, two Ar atoms bonded to the same nitrogen atom 1 group, or an Ar bonded to the same nitrogen atom 1 The group and an L group can also be bonded to each other, for example to give carbazole.

[0190] Preferred carbazole amines are the following structures (87), (88) and (89):

[0191]

[0192] wherein L is an aromatic or heteroaromatic ring system having 5 to 30 aromatic ring atoms and which may be substituted by one or more R groups, and R and Ar 1has the definitions given above.

[0193] Preferred triazine, quinazoline or pyrimidine derivatives which can be used as a mixture with the compounds of the invention are compounds of the following formulae (90), (91) and (92):

[0194]

[0195] Among them, Ar 1 and R have the definitions given above.

[0196] Particularly preferred are triazine derivatives of the formula (90) and quinazoline derivatives of the formula (92), especially triazine derivatives of the formula (90).

[0197] In a preferred embodiment of the present invention, Ar in formulas (90), (91) and (92) 1 are in each case identical or different and are aromatic or heteroaromatic ring systems having 6 to 30 aromatic ring atoms, in particular 6 to 24 aromatic ring atoms, and which may be substituted by one or more R radicals. Suitable aromatic or heteroaromatic ring systems Ar here are: 1 With the above Ar 1 ,Ar 2 and Ar 3 The embodiments are the same, especially structures Ar-1 to Ar-76.

[0198] Examples of suitable triazine compounds that can be used as matrix materials together with the compounds of the present invention are the compounds depicted in the following table:

[0199]

[0200]

[0201]

[0202]

[0203] It is also preferred to use a mixture of two or more triplet luminophores and a matrix. In this case, the triplet luminophore with a shorter emission spectrum is used as a co-matrix for a triplet luminophore with a longer emission spectrum. For example, the complex of formula (1) according to the invention can be used as a co-matrix for a longer-wave emitting triplet luminophore, for example as a co-matrix for a triplet luminophore emitting green or red light.

[0204] The compounds of the present invention can also be used for other functions in electronic devices, for example as hole transport materials in hole injection layers or hole transport layers, as charge generating materials or as electron blocking materials. It is also possible to use the complexes of the present invention as matrix materials for other phosphorescent metal complexes in the emitting layer.

[0205] The preferred cathode is a metal with a low work function, a metal alloy or a multilayer structure consisting of a variety of metals, such as alkaline earth metals, alkali metals, main group metals or lanthanides (such as Ca, Ba, Mg, Al, In, Mg, Yb, Sm, etc.). In addition, an alloy consisting of an alkali metal or alkaline earth metal and silver, such as an alloy consisting of magnesium and silver, is suitable. In the case of a multilayer structure, in addition to the metal, other metals with a relatively high work function, such as Ag, can also be used. In this case, a combination of metals, such as Mg / Ag, Ca / Ag or Ba / Ag, is generally used. It is also preferred to introduce a thin intermediate layer of a material with a high dielectric constant between the metal cathode and the organic semiconductor. Examples of useful materials for this purpose are alkali metal or alkaline earth metal fluorides, and corresponding oxides or carbonates (such as LiF, Li2O, BaF2, MgO, NaF, CsF, Cs2CO3, etc.). Organic alkali metal complexes such as Liq (hydroxyquinoline lithium) are also suitable for this purpose. The layer thickness of this layer is preferably 0.5 to 5nm.

[0206] Preferred anodes are materials with high work function. Preferably, the anode has a work function greater than 4.5 eV relative to vacuum. Firstly, metals with high redox potentials, such as Ag, Pt or Au, are suitable for this purpose. Secondly, metal / metal oxide electrodes (such as Al / Ni / NiO x 、Al / PtO x ) may also be preferred. For some applications, at least one electrode must be transparent or partially transparent in order to enable radiation of organic materials (O-SC) or light emission (OLED / PLED, O-laser). The preferred anode material here is a conductive mixed metal oxide. Indium tin oxide (ITO) or indium zinc oxide (IZO) is particularly preferred. Further preferred are conductive doped organic materials, especially conductive doped polymers, such as PEDOT, PANI or derivatives of these polymers. In addition, it is preferred that a p-doped hole transport material is applied to the anode as a hole injection layer, in which case a suitable p-type dopant is a metal oxide, such as MoO3 or WO3, or a (per) fluorinated electron-deficient aromatic system. Other suitable p-type dopants are HAT-CN (hexacyanohexaazatriphenylene fork) or the compound NPD9 from Novaled. This layer simplifies hole injection in materials with a low HOMO (i.e., a large HOMO in terms of magnitude).

[0207] In the further layers, generally any material used according to the prior art for said layers can be used, and the person skilled in the art will be able to combine any of these materials with the material of the invention in an electronic device without inventive step.

[0208] The components are structured accordingly (depending on the application), contact-connected and finally hermetically sealed, since the lifetime of such components is severely shortened in the presence of water and / or air.

[0209] Furthermore, preference is given to organic electroluminescent devices which are characterized in that one or more layers are applied by a sublimation process. In this case, the material is sublimated in a vacuum system at a temperature of typically less than 10 -5 mbar, preferably less than 10 -6 The material is applied by vapor deposition at an initial pressure of 10 mbar. The initial pressure can also be lower or higher, for example less than 10 -7 millibar.

[0210] Preference is likewise given to an organic electroluminescent device, characterized in that one or more layers are applied by the OVPD (organic vapor phase deposition) method or by means of carrier gas sublimation. -5 The material is applied at a pressure of mbar to 1 bar. A special example of this method is the OVJP (Organic Vapor Jet Printing) method, in which the material is applied directly via a nozzle and is thus structured (eg MS Arnold et al., Appl. Phys. Lett. 2008, 92, 053301).

[0211] In addition, preference is given to organic electroluminescent devices, characterised in that one or more layers are produced from solution, for example by spin coating, or by any printing method, for example screen printing, flexographic printing, lithography or nozzle printing, but more preferably LITI (light-induced thermal imaging, thermal transfer) or inkjet printing. For this purpose, soluble compounds are required, which are obtained, for example, by suitable substitution.

[0212] Organic electroluminescent devices can also be manufactured as hybrid systems by applying one or more layers from a solution and applying one or more other layers by vapor deposition. For example, a light-emitting layer comprising a compound of formula (1) and a matrix material can be applied from a solution, and a hole blocking layer and / or an electron transport layer can be applied thereto by reduced pressure vapor deposition.

[0213] These methods are generally known to those skilled in the art, and they can apply them to organic electroluminescent devices comprising the compound of formula (1) or the preferred embodiments described in detail above without difficulty.

[0214] The electronic devices according to the invention, in particular the organic electroluminescent devices, are notable for good color coordinates, good efficiency and a long lifetime.

[0215] The present invention is explained in more detail by the following examples, but it is not intended to be limited thereby. A person skilled in the art will be able to use the given details to produce other electronic devices of the present invention without inventive effort, and thus implement the present invention within the entire scope of the claimed protection.

[0216] Example:

[0217] Unless otherwise stated, the subsequent synthesis was carried out in dry solvents under a protective gas atmosphere. The metal complexes were additionally handled in the dark or under yellow light. Solvents and reagents can be purchased, for example, from Sigma-ALDRICH or ABCR. The corresponding numbers in square brackets or the numbers quoted for individual compounds relate to the CAS numbers of the compounds known from the literature. In the case where a compound can have a plurality of enantiomeric, diastereomeric or tautomeric forms, one form is shown in a representative manner.

[0218] A: Synthesis of Synthon S:

[0219] Example S1:

[0220]

[0221] To a mixture of 29.8 g (100 mmol) of 11-bromobenzo[c]imidazo[1,2-a][1,5]naphthyridine [2253277-62-9], 26.7 g (105 mmol) of bis(pinacol)diborane, 29.4 g (300 mmol) of potassium acetate (anhydrous), 50 g of glass beads (3 mm in diameter) and 500 ml of THF, 821 mg (2 mmol) of SPhos and 225 mg (1 mmol) of palladium(II) acetate were added successively with good stirring, and the mixture was heated under reflux for 16 hours. While the mixture was still warm, the salts and glass beads were removed by suction filtration as a THF slurry through a diatomaceous earth bed, the diatomaceous earth bed was washed thoroughly with THF, and the filtrate was concentrated to dryness. The residue was dissolved in 100 ml of MeOH and stirred in the warm solvent, and the crystalline product was filtered off with suction, washed twice with 30 ml of methanol each time and dried under reduced pressure. Yield: 30.0 g (81 mmol), 81%; Purity: according to 1 H-NMR was about 95%.

[0222] The following compounds can be prepared similarly:

[0223]

[0224]

[0225] Embodiment S50:

[0226]

[0227] To a mixture of 34.5 g (100 mmol) of S1, 28.3 g (100 mmol) of 1-bromo-2-iodobenzene [583-55-1], 31.8 g (300 mmol) of sodium carbonate, 300 ml of toluene, 100 ml of ethanol and 300 ml of water, 788 mg (3 mmol) of triphenylphosphine and 225 mg (1 mmol) of palladium (II) acetate are added in sequence with good stirring, and the mixture is heated under reflux for 48 hours. After cooling, the organic phase is removed and washed once with 300 ml of water and once with 300 ml of saturated sodium chloride solution and dried over magnesium sulfate. The desiccant is filtered off and the filtrate is completely concentrated under reduced pressure. The residue is subjected to flash chromatography (Torrent automatic column system from A. Semrau) or recrystallized from acetonitrile / ethyl acetate. Yield: 31.8 g (85 mmol), 85%; purity: according to 1 H-NMR is about 95%. The following compounds can be prepared similarly:

[0228]

[0229] Synthesis of B ligand L:

[0230] 1) Synthesis of tetradentate ligand TL: Example TL1:

[0231]

[0232]

[0233] 59.0 ml (100 mmol) of tert-butyl lithium (1.7 M in n-pentane) was added dropwise to a suspension of 15.2 g (50 mmol) of 6-chlorobenzimidazolo[2,1-f]benzo[h][1,6]naphthyridine [1228276-32-0] in 200 ml THF cooled to -78°C, and the mixture was stirred for another 2 hours. Then 10.8 g (60 mmol) of 3-(2-pyridyl)benzonitrile [4350-51-0] solution precooled to -78°C was added dropwise, and the mixture was stirred for another 1 hour at -78°C, and then allowed to gradually warm to room temperature. The reaction mixture was quenched by adding 20 ml of methanol, followed by 100 ml of 5N hydrochloric acid and the mixture was heated under reflux for 2 hours. The mixture was adjusted to pH 9 by adding 5N NaOH aqueous solution and extracted three times with 200 ml of dichloromethane each time. The combined organic phases were washed three times with 300 ml of water each time and once with 300 ml of saturated sodium chloride solution and dried over magnesium sulfate. The desiccant was filtered off with suction and washed thoroughly with dichloromethane, and the filtrate was concentrated to dryness. The crude product was chromatographed on silica gel with dichloromethane / ethyl acetate (8:2 vv). Yield: 7.7 g (17 mmol) 34%; purity: according to 1 H-NMR was about 95%.

[0234] B)

[0235] To a solution of 7.0 g (30 mmol) of 2-bromobiphenyl [2052-07-5] in 100 ml of THF which had been cooled to -78°C, 12.0 ml (30 mmol) of n-butyllithium (2.5 N in hexane) were added dropwise, and the mixture was stirred for a further 30 minutes. A solution of 13.5 g (30 mmol) of TL1 stage A) in 200 ml of THF was then added dropwise, and the mixture was slowly warmed to room temperature and stirred for a further 6 hours. The reaction mixture was quenched by addition of 10 ml of ethanol, the solvent was completely evaporated off under reduced pressure, the residue was dissolved in 200 ml of glacial acetic acid, 1 ml of concentrated sulfuric acid was added dropwise with stirring, and the mixture was stirred for a further 3 hours at 60°C. The glacial acetic acid was then removed in large quantities under reduced pressure, the residue was dissolved in 300 ml of dichloromethane, and the mixture was alkalified by addition of a 5% by weight aqueous NaOH solution while cooling with ice. The organic phase was separated, washed three times with 200 ml of water each time and dried over magnesium sulfate, the organic phase was completely concentrated, and the residue was dissolved in 300 ml of methanol, homogenized under heating and then stirred for a further 12 hours, during which the product crystallized. The crude product was filtered off with suction, washed twice with 30 ml of methanol each time, dried under reduced pressure and recrystallized twice from toluene:isopropanol (5:1). Yield: 6.5 g (11 mmol) 37%; purity: according to 1 H-NMR was about 95%.

[0236]

[0237]

[0238] 2) Synthesis of hexadentate ligand HL:

[0239] Example HL1:

[0240]

[0241] 66.3 g (100 mmol) of 2,2'-[5"-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)[1,1':2',1":3",1"':2"',1""-pentaphenyl]-4,4""-diyl]bipyridine [1989597-72-9], 37.4 g (100 mmol) of S50, 63.7 g (300 mmol) of tripotassium phosphate, 300 ml of toluene, and 150 ml of distilled water were added. To a mixture of oxane and 300 ml of water, 1.64 g (4 mmol) of SPhos and 449 mg (2 mmol) of palladium (II) acetate are added in sequence with good stirring, and the mixture is then heated under reflux for 24 hours. After cooling, the organic phase is removed and washed twice with 300 ml of water each time and once with 300 ml of saturated sodium chloride solution and dried over magnesium sulfate. The desiccant is filtered off, the filtrate is concentrated to dryness under reduced pressure, and the glassy crude product is recrystallized from acetonitrile (about 150 ml) at boiling and then recrystallized a second time from acetonitrile / ethyl acetate. Yield: 58.1 g (70 mmol), 70%; purity: according to 1 H-NMR was about 95%.

[0242]

[0243]

[0244]

[0245] Synthesis of C metal complexes:

[0246] 1) Synthesis of IrL3 type homogeneous iridium complex:

[0247] Uniformly matched three-sided iridium complex:

[0248] Variant A: Tris(acetylacetonate)iridium(III) as iridium reactant

[0249] A mixture of 10 mmol of tris(2,2,6,6-tetramethyl-3,5-heptanedione)iridium(III)[99581-86-9] and 60 mmol of ligand L was stirred under reduced pressure (10 -5 The ampoule is melted and sealed in a 50ml glass ampoule at 4000 mbar. The ampoule is heated at a specified temperature for a specified time, and the molten mixture is stirred by means of a magnetic stirrer in the process. High boiling alkane, such as octadecane, is added when appropriate. After cooling (warning: the ampoule is usually under pressure!), the ampoule is opened, and the sintered cake is stirred and mechanically digested with 100g glass beads (3mm in diameter) in the specified suspension medium of 100ml. From the glass beads, a fine suspension is decanted, and solids are filtered out and dried under reduced pressure. The solid is dissolved in dichloromethane, adsorbed on Isolute SI (from Biotage), and then column chromatography is carried out on silica gel with dichloromethane. Further purification is achieved by repeated hot extraction. The solid is placed on the top of a 5cm alumina bed (alumina, basic activity level 1), then extracted with a specified extraction agent (initial charge is about 500ml). From the suspension thus obtained, solids are filtered out, washed once and dried with about 50ml methanol. After drying, the purity of the metal complex is determined by NMR and / or HPLC. If the purity is less than 99.5%, the hot extraction step is repeated. Once a purity of 99.5% to 99.9% is reached, the metal complex is heat treated or sublimed. The metal complex is subjected to a high vacuum (p of about 10°C) in the temperature range of 200 to 350°C. -6 The heat treatment is carried out at a temperature range of about 320 to about 450° C. in a high vacuum (p is about 10 -6 The sublimation is preferably carried out in the form of fractionated sublimation.

[0250]

[0251] 2) Synthesis of L'2IrL type heteroleptic iridium complex:

[0252] To a well-stirred suspension of 5 mmol of the designated iridium reactant of type [L2IrCl]2, 10 mmol of ligand L and 50 g of glass beads (3 mm in diameter) in 200 ml of 1,2-dichloromethane, 60 mmol of triethylamine and 10 mmol of silver trifluoromethanesulfonate were added in sequence, and the mixture was stirred at 90°C for 24 hours. While the mixture was still warm, the precipitated silver chloride was filtered out in the form of a slurry using a silica gel bed, the silica gel bed was washed thoroughly with a small amount of 1,2-dichloroethane, and the filtrate was concentrated to dryness. Subsequently, the crude product was chromatographed on silica gel (eluent: dichloromethane, toluene, ethyl acetate, acetone, THF, cyclohexane, n-heptane, etc.; and / or mixtures thereof). Further purification was achieved by repeated hot extraction and heat treatment or fractional sublimation under high vacuum as described in 1).

[0253]

[0254]

[0255]

[0256] 3) Synthesis of Pt complexes using Pt(TL) type tetradentate ligands:

[0257] A mixture of 10 mmol ligand L, 10 mmol K2PtCl4, 400 mmol lithium acetate (anhydrous) and 200 ml glacial acetic acid was heated to 150 ° C in a stirred autoclave for 60 hours. After cooling and adding 200 ml of water, the precipitated solid was filtered out, and these were extracted twice by stirring in 200 ml of hot ethanol / water (1:1 vv), filtered with suction and washed three times with 50 ml of ethanol each time. Subsequently, the crude product was chromatographed on silica gel (eluent: dichloromethane, toluene, ethyl acetate, acetone, THF, cyclohexane, n-heptane, etc.; and / or mixtures thereof). Further purification was achieved by repeated hot extraction and heat treatment or fractional sublimation under high vacuum as described in 1).

[0258]

[0259]

[0260] 4) Synthesis of iridium complexes using Ir(HL) type hexadentate ligands:

[0261] First, a mixture of 10 mmol of ligand HL, 4.90 g (10 mmol) of iridium (III) triacetylacetonate [15635-87-7] and 120 g of hydroquinone [123-31-9] was placed in a 1000 ml two-necked round-bottom flask with a glass-sheathed magnetic bar. The flask was equipped with a water separator (for media with a density lower than that of water) and an air condenser with an argon blanket. The flask was placed in a metal heating bath. The apparatus was purged with argon from the top for 15 minutes via an argon blanket system, allowing argon to flow out of the side neck of the two-necked flask. A glass-sheathed Pt-100 thermocouple was introduced into the flask through the side neck of the two-necked flask and the end was placed just above the magnetic stirring bar. The apparatus was then insulated with several turns of loose domestic aluminum foil windings, extending to the middle of the riser of the water separator. The apparatus is then rapidly heated to 250°C-255°C with a heated laboratory stirrer system, measured with a Pt-100 temperature sensor immersed in the molten stirred reaction mixture. Over the next 2 hours, the reaction mixture is maintained at 250°C-255°C, during which a small amount of condensate is distilled off and collected in a water separator. After 2 hours, the mixture is cooled to 190°C, the heating bath is removed, and then 100 ml of ethylene glycol is added dropwise. After cooling to 100°C, 400 ml of methanol are slowly added dropwise. The yellow suspension thus obtained is filtered through a double-ended glass frit, and the yellow solid is washed three times with 50 ml of methanol and then dried under reduced pressure. Crude yield: quantitative. The solid thus obtained is dissolved in 200 ml-500 ml of dichloromethane and filtered in the dark through about 1 kg of silica gel in the form of a dichloromethane slurry with exclusion of air (column diameter about 18 cm), leaving dark components at the beginning. The core fraction is removed and concentrated on a rotary evaporator, while MeOH is continuously added dropwise until crystallization. After filtration with suction, washing with a small amount of MeOH and drying under reduced pressure, the orange product is further purified by three consecutive hot extractions with dichloromethane / isopropanol 1:1 (vv), then four hot extractions with dichloromethane / acetonitrile under careful exclusion of air and light (initial charge in each case about 200 ml, extraction thimble: standard Soxhlet thimble made of cellulose from Whatman). The loss in the mother liquor can be adjusted via the ratio of dichloromethane (low boiler and good solubilizer): isopropanol or acetonitrile (high boiler and poor solubilizer). It should generally be 3% to 6% by weight of the amount used. Other solvents such as toluene, xylene, ethyl acetate, butyl acetate, etc. can also be used to achieve hot extraction. Finally, the product is concentrated under high vacuum at a p of about 10 -6 Fractional sublimation is carried out at 100 mbar and T of about 350° C. to 430° C. Purity is typically >99.7%.

[0262]

[0263]

[0264]

[0265] Example: Fabrication of OLEDs

[0266] 1) Vacuum processed devices:

[0267] The OLEDs according to the invention and the OLEDs according to the prior art were produced by the general method according to WO 2004 / 058911, which was adapted to the cases described here (variation of layer thicknesses, materials used). In the following examples, the results for various OLEDs are provided. Clean glass plates (cleaned in a Miele laboratory glass washer, Merck Extran detergent) coated with structured ITO (indium tin oxide) with a thickness of 50 nm were pretreated with UV ozone for 25 minutes (PR-100 UV ozone generator from UVP) and, within 30 minutes, to improve processing, coated with 20 nm of PEDOT:PSS (poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate) as CLEVIOS TM P VP AI 4083 was purchased from Heraeus PreciousMetals GmbH Deutschland and was spin-coated from aqueous solution) and then baked for 10 minutes at 180° C. These coated glass plates formed the substrate to which the OLEDs were applied.

[0268] The OLEDs essentially have the following layer structure: substrate / hole injection layer 1 (HIL1) consisting of HTM1 doped with 5% NDP-9 (available from Novaled), 20 nm / hole transport layer 1 (HTL1) consisting of HTM1, 220 nm for green / yellow devices, 110 nm for red devices / hole transport layer 2 (HTL2) / emissive layer (EML) / hole blocking layer (HBL) / electron transport layer (ETL) / optional electron injection layer (EIL) and finally cathode. The cathode is formed by an aluminum layer with a thickness of 100 nm.

[0269] First, a vacuum-processed OLED is described. For this purpose, all materials are applied by thermal vapor deposition in a vacuum chamber. In this case, the light-emitting layer always consists of at least one matrix material (host material) and a luminescent dopant (luminophore) added to the matrix material in a specific volume ratio by co-evaporation. The details given in the form of M1:M2:Ir(L1) (55%:35%:10%) mean here that the material M1 is present in the layer in a volume ratio of 55%, M2 is present in the layer in a volume ratio of 35% and Ir(L1) is present in the layer in a volume ratio of 10%. Similarly, the electron transport layer can also consist of a mixture of two materials. The exact structure of the OLED light-emitting layer can be seen in Table 2. The materials used to manufacture the OLED are shown in Table 4.

[0270] The OLEDs were characterized in a standard manner. For this purpose, the electroluminescence spectrum was determined, the current efficiency (measured in cd / A), the power efficiency (measured in lm / W) and the external quantum efficiency (EQE, measured in percent) were calculated as a function of the luminous density from the current-voltage-luminous density characteristic (IUL characteristic) which exhibits Lambertian luminescence behavior, and the lifetime was determined. 2 The electroluminescence spectra at luminous densities of 1000 cd / m2 are obtained and these are used to calculate the CIE 1931 x and y color coordinates. The lifetime LD50 is defined as the lifetime at an initial luminance of 1000 cd / m2. 2 The time after which the working luminous density drops to 50% of the initial luminous density.

[0271] The OLED can also be initially operated at different initial luminous densities. The lifetime value can then be converted into figures for other initial luminous densities with the aid of conversion formulas known to those skilled in the art.

[0272] Use of the compounds of the present invention as luminescent materials in phosphorescent OLEDs

[0273] One use of the compounds according to the invention is as phosphorescent emitter material in the light-emitting layer of OLEDs. The results for the OLEDs are collated in Table 2.

[0274] Table 1: Structure of OLED

[0275]

[0276]

[0277]

[0278] Table 2: Results for vacuum processed OLEDs

[0279]

[0280] Solution Processed Devices:

[0281] A: Processing from low molecular weight soluble functional materials

[0282] The iridium complex of the present invention can also be processed from solution and produce therein an OLED which is much simpler in processing technology than vacuum processed OLED but still has good performance. The manufacture of such components is based on the manufacture of polymer light-emitting diodes (PLEDs), which have been described many times in the literature (e.g. in WO 2004 / 037887). The structure consists of substrate / ITO / hole injection layer (60nm) / intermediate layer (20nm) / luminescent layer (60nm) / hole blocking layer (10nm) / electron transport layer (40nm) / cathode. For this purpose, a substrate from Technoprint (soda-lime glass) is used to which an ITO structure (indium tin oxide, transparent conductive anode) is applied. The substrate is cleaned in a clean room with deionized water and detergent (Deconex 15PF) and then activated by UV / ozone plasma treatment. Then, also in a clean room, a 20nm hole injection layer is applied by spin coating. The required rotation rate depends on the dilution degree and the specific spin coater geometry. To remove residual water from the layer, the substrate was baked on a hotplate at 200° C. for 30 minutes. The intermediate layer used serves for hole transport; in this case, HL-X from Merck was used. Alternatively, the intermediate layer can also be replaced by one or more layers, which only have to meet the condition that they are not leached out again by the subsequent processing steps of the EML deposition from solution. To produce the emitting layer, the triplet emitter according to the invention is dissolved in toluene or chlorobenzene together with the matrix material. The typical solids content of these solutions is 16 g / l to 25 g / l, and here, the layer thickness of 60 nm typical for the devices is achieved by spin coating. Solution-processed devices of type 1 contain an emitting layer composed of M4:M5:IrL (20%:58%:22%), while solution-processed devices of type 2 contain an emitting layer composed of M4:M5:IrLa:IrLb (30%:34%:29%:7%); in other words, they contain two different Ir complexes. In the case of materials processed from solution, the percentage figures refer to weight %. The light-emitting layer was spin-coated in an inert gas atmosphere (argon in this case) and baked at 160°C for 10 minutes. On the latter, a hole blocking layer (10 nm ETM1) and an electron transport layer (40 nm ETM1 (50%) / ETM2 (50%)) were vapor-deposited (vapor deposition system from Lesker et al., typical vapor deposition pressure 5×10 -6mbar). Finally, an aluminum cathode (100 nm) was applied by vapor deposition (high purity metal from Aldrich). To protect the device from air and air humidity, the device was finally encapsulated and then characterized. The cited OLED examples have not yet been optimized. Table 3 summarizes the data obtained. The lifetime LD50 is defined as the lifetime at an initial brightness of 1000 cd / m 2 The time after which the working luminous density drops to 50% of the initial luminous density.

[0283] Table 3: Results for materials processed from solution

[0284]

[0285] Table 4: Structural formula of materials used

[0286]

[0287]

[0288] Comparison with existing technologies

[0289] The complexes described below are known from US 2012 / 0153816 which have ligands similar to the complexes according to the invention, wherein the ligands are coordinated here via a five-membered ring and a six-membered ring instead of via two six-membered rings according to the invention.

[0290]

[0291] For both complexes, CIE color coordinates of CIE x / y 0.19 / 0.28 are reported.The complexes coordinated to the iridium via one five-membered ring and one six-membered ring therefore exhibit blue emission, whereas the complexes according to the invention exhibit green, yellow or red emission.

Claims

1. A compound of formula (1), M(L) n (L') m Formula (1) The compound contains the substructure M(L) of formula (2) n : The symbols and notations used are as follows: M is iridium or platinum; D is C or N, one of D is C and the other D is N; X is the same or different in each instance and is CR or N; R is identical or different in each case and is H, D, F, Cl, Br, I, N (R 1 )2,CN,NO2,OR 1 , SR 1 ,COOR 1 ,C(=O)N(R 1 )2,Si(R 1 )3,B(OR 1 )2,C(=O)R 1 , P(=O)(R 1 )2,S(=O)R 1 , S(=O)2R 1 ,OSO2R 1 , a straight-chain alkyl group having 1 to 20 carbon atoms, or an alkenyl or alkynyl group having 2 to 20 carbon atoms, or a branched or cyclic alkyl group having 3 to 20 carbon atoms, wherein the alkyl, alkenyl or alkynyl group may in each case be replaced by one or more R 1 group, wherein one or more non-adjacent CH2 groups may be replaced by Si(R 1 )2. C=O、NR 1 , O, S or CONR 1 or having 5 to 60 aromatic ring atoms, preferably 5 to 40 aromatic ring atoms and in each case being replaced by one or more R 1 Aromatic or heteroaromatic ring systems substituted with R groups; at the same time, the two R groups together can also form an aliphatic, heteroaliphatic, aromatic or heteroaromatic ring system; R 1 are the same or different in each case and are H, D, F, Cl, Br, I, N (R 2 )2,CN,NO2,OR 2 , SR 2 ,Si(R 2 )3,B(OR 2 )2,C(=O)R 2 , P(=O)(R 2 )2,S(=O)R 2 , S(=O)2R 2 ,OSO2R 2 , a linear alkyl group having 1 to 20 carbon atoms, or an alkenyl or alkynyl group having 2 to 20 carbon atoms, or a branched or cyclic alkyl group having 3 to 20 carbon atoms, wherein the alkyl, alkenyl or alkynyl group may be each replaced by one or more R 2 group, wherein one or more non-adjacent CH2 groups may be replaced by Si(R 2 )2. C=O、NR 2 , O, S or CONR 2 wherein one or more hydrogen atoms in the alkyl, alkenyl or alkynyl group may be replaced by D, F, Cl, Br, I or CN, or have 5 to 40 aromatic ring atoms and in each case by one or more R 2 Aromatic or heteroaromatic ring system substituted with a group; at the same time, two or more R 1 The groups together may form an aliphatic, heteroaliphatic, aromatic or heteroaromatic ring system; R 2 are in each case identical or different and are H, D, F, CN, or an aliphatic, aromatic or heteroaromatic organic radical having 1 to 20 carbon atoms, in particular a hydrocarbon radical, in which one or more hydrogen atoms may also be replaced by F; L' is in each case identical or different and is a ligand; n is 1, 2, or 3; m is 0, 1, 2, 3, or 4; At the same time, two or more ligands L may be linked together or L may be linked to L' via a single bond or a divalent or trivalent bridging group to form a tridentate, tetradentate, pentadentate or hexadentate ligand system.

2. The compound according to claim 1, characterized in that The unit of formula (2) is selected from the structure of formula (3) or (4), The symbols and signs used therein have the same meanings as defined in claim 1.

3. The compound according to claim 1 or 2, characterized in that The unit of formula (2) is selected from the structures of formulae (3a) to (3f) and (4a) to (4f), The symbols and signs used herein have the definitions given in claim 1.

4. Compounds according to one or more of claims 1 to 3, characterized in that The unit of formula (2) is selected from the structures of formula (3a-1) to (4f-1), The symbols and indices used therein have the meanings given in claim 1, and R' has the same meaning as R, wherein at least one substituent R' is not H or D.

5. Compounds according to one or more of claims 1 to 4, characterized in that The unit of formula (2) is selected from the structures of formula (3a-2) to (4a-6), The symbols and signs used herein have the definitions given in claim 1.

6. Compounds according to one or more of claims 1 to 5, characterized in that R is identical or different at each occurrence and is selected from H, D, F, Br, I, N (R 1 )2,CN,Si(R 1 )3,B(OR 1 )2, a straight-chain alkyl group having 1 to 10 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms, or a branched or cyclic alkyl group having 3 to 10 carbon atoms, each of which may be replaced by one or more R 1 a substituted radical in which one or more hydrogen atoms may be replaced by D or F, or having 5 to 24 aromatic ring atoms and in each case by one or more R 1 At the same time, two preferably adjacent R groups can also together form an aliphatic, heteroaliphatic, aromatic or heteroaromatic ring system.

7. A compound according to one or more of claims 1 to 6, selected from the structures of formulae (12) to (15), The symbols and signs used herein have the definitions given in claim 1.

8. The compound according to claim 7, characterized in that V in the compounds of formula (12) and (13) is a group of formula (26), wherein the dotted bond indicates the connection position of the sub-ligands L and L', in: X 1 are the same or different and are CR or N in each case; X 2 are the same or different and are CR or N in each case; A is identical or different in each case and is CR2-CR2, CR2-O, CR2-NR, C(=O)-O, C(=O)-NR or a radical of the following formula (27): Therein, the dashed bond in each case indicates the bonding position of the bidentate ligand L or L′ to this structure, and * indicates the attachment position of the unit of the formula (27) to the central trivalent aryl or heteroaryl group.

9. The compound according to claim 7 or 8, characterized in that V in the compounds of formulae (12) and (13) represents a structure of one of formulae (36) to (39), The symbols used herein have the definitions given in claim 1.

10. Compounds according to one or more of claims 1 to 9, characterized in that L' is in each case identical or different and is a bidentate monoanionic ligand.

11. Compounds according to one or more of claims 1 to 10, characterized in that All X are CR.

12. A process for preparing compounds according to one or more of claims 1 to 11, said process being carried out by reacting the free ligand L and optionally L′ with a metal alkoxide of formula (79), with a metal keto-ketonate of formula (80), with a metal halide of formula (81), with a dimeric metal complex of formula (82) or with a metal complex of formula (83), wherein the symbols M, m, n and R have the definitions given in claim 1, Hal═F, Cl, Br or I, L″ is an alcohol or nitrile and (anion) is a non-coordinating anion.

13. A preparation comprising at least one compound according to one or more of claims 1 to 11 and at least one further compound and / or at least one solvent.

14. An electronic device comprising at least one compound according to one or more of claims 1 to 11.

15. The electronic device according to claim 14, wherein the electronic device is an organic electroluminescent device, characterized in that The compounds according to one or more of claims 1 to 11 are used as emitting compounds in one or more emitting layers in combination with one or more matrix materials.

Images